Document is current

Article History

Received: 4 June 2020

Accepted: 5 November 2020

First Online: 13 November 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Nadia Waheed receives financial support from a Massachusetts Lions Club Grant (Boston, Massachusetts, USA) and a Research to Prevent Blindness Challenge Grant (New York, New York, USA). She is a consultant for Topcon (Tokyo, Japan), Roche/Genentech (San Francisco, California, USA), Regeneron (Tarrytown, New York, USA), Apellis (Waltham, Massachusetts, USA), Astellas (Tokyo, Japan), Boehringer Ingelheim (Ingelheim, Germany), Novartis (Basel, Germany). She is a speaker for Nidek Medical Products (Gamagori, Japan) and Topcon (Tokyo, Japan). She is an officer of entity at Gyroscope (Ambler, Pennsylvania, USA). She has a personal financial interest in the Boston Imaging Reading Center (Boston, Massachusetts, USA) and Ocudyne. Dr. Jay S. Duker receives financial support from Carl Zeiss Meditec (Jena, Germany) and Optovue Inc (Fremont, CA, USA). He is a consultant at Aldeyra Therapeutics (Lexington, MA, USA), Allergan Pharmaceuticals (Dublin, Ireland), Aura Biosciences (Cambridge, MA, USA), Bausch Health (Laval, Canada), Beyeonics (Haifa, Israel), Merck (Kenilworth, NJ, USA), Novartis (Basel, Switzerland) and Roche (Basel, Switzerland). He is a director of entity at Sesen Bio (Cambridge, Massachusetts, USA) and Eye-Point Pharma (Watertown, MA, USA). He is a shareholder at Hemera Biosciences (Waltham, MA, USA). Eugenia Custo Greig has no financial disclosures or competing interests.